A recent article in the Capital Business Journal, a Washington Post publication, about diversifying the local economy included information about how Children’s National is using data to help improve care for children with chronic conditions like sickle cell disease.
Read the article
Want the latest Children’s National news and stories as they happen? Sign up to get our News & Events releases by email.
Bone marrow transplant is the only treatment that can cure sickle cell disease, but only 20-30 percent of patients who need one have a matching sibling to donate bone marrow for them.
Sickle cell disease is an inherited blood disorder characterized by defective hemoglobin (a protein in red blood cells that carries oxygen to the tissues of the body).
Our blood and marrow transplant offers trials for cellular therapy to reduce infection and relapse in children with cancer
Allogeneic transplantation is a procedure in which a person receives hematopoietic (blood-forming) or blood stem cells, from a genetically similar, but not identical, donor.